Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Hypersonic missiles to help Japan counter escalating security challenges in Indo-Pacific region, says GlobalData

The deployment of the Hyper Velocity Guided Projectile (HVGP) will be a significant shift in Japan’s defense strategy, which has historically committed to a purely defensive posture. Japan is now poised to integrate this hypersonic missile into its force structure to conduct offensive operations when required. The advancements in missile technology by China and North […]
Read more

Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom, says GlobalData

The pharmaceutical industry is bracing for one of its most financially significant patent cliffs in over a decade, with multiple blockbuster drugs set to lose exclusivity by 2030. As biosimilars and generics flood the market, pricing pressures will intensify—particularly in oncology—challenging pharma companies to rethink revenue strategies, pipeline investments, and lifecycle management to safeguard long-term […]
Read more

Lineage Cell Therapeutics’ OpRegen holds potential to become new treatment option for GA, says GlobalData

Lineage Cell Therapeutics’ OpRegen (RG6501) is gaining attention as a promising one-time allogenic cell therapy for geographic atrophy (GA), following encouraging results from its Phase I/IIa trial. With limited treatment options currently available, OpRegen’s ability to improve and stabilize vision positions it as a potential breakthrough in addressing a critical unmet need in GA management, […]
Read more

Trade agreements offer some relief from tariffs, but do not deliver the clarity businesses need, says GlobalData

Trade agreements have long been seen as a means to alleviate the financial and logistical burdens created by tariffs. While lowering or eliminating certain duties can provide temporary relief and facilitate access to new markets, they fall short of delivering long-term certainty and stability or addressing the deeper structural issues businesses face in a volatile […]
Read more

As UK-US trade deal takes effect, US consumers express greater concern about potential impact of tariffs compared to UK counterparts, says GlobalData

The “fantastic” UK-US trade deal came into effect at 5.01am, Monday June 30th, eight weeks after it was hailed as a breakthrough deal between Prime Minister Sir Keir Starmer and President Donald Trump. With Prime Minister Starmer claiming that it “delivers for British businesses and protects UK jobs”, it also gives the US administration a […]
Read more

Challenges mount for big pharma in China as vaccine sales plummet, says GlobalData

Multinational pharmaceutical companies (MNCs) are facing significant challenges in China’s vaccine market, as regulatory scrutiny, domestic competition, and changing consumer behaviors disrupt a once-thriving sector. Major players like Merck & Co. and GSK are re-evaluating their strategies in light of these developments, says GlobalData, a leading data and analytics company. GlobalData’s Q2 2025 Emerging Market […]
Read more

High costs and limited access threaten progress in HIV treatment despite new drug advances, says GlobalData

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious challenges that threaten long-term control of the disease. The most pressing issue is the lack of affordable access to newer therapies, which—despite offering better adherence and fewer side effects—remain out of reach for many patients due to high costs […]
Read more

Vutrisiran to change ATTR-CM treatment paradigm in Europe, says GlobalData

Transthyretin amyloidosis (ATTR) is a protein conformational disorder caused by the build-up of transthyretin, the protein carrying thyroxine and retinol in the bloodstream. It can cause ATTR-cardiomyopathy (ATTR-CM) or ATTR-polyneuropathy (ATTR-PN). As effective treatments for ATTR-CM are still limited, Alnylam Pharmaceuticals’ drug vutrisiran is expected to change ATTR-CM treatment paradigm upon market launch in Europe, […]
Read more

Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData

The nontuberculous mycobacteria (NTM) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 8.8% from $2.0 billion in 2023 to $4.6 billion in 2033, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast”, reveals that […]
Read more

New CGM-enabled insulin delivery systems address demand for automated diabetes care, says GlobalData

With around 2 million Americans living with type 1 diabetes, and an increasing number of insulin-requiring type 2 cases, the US healthcare system is experiencing growing demand for simplified, automated diabetes care. The integration of Abbott Laboratories’ FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with the Tandem t:slim X2 insulin pump system marks a […]
Read more
1 … 57 58 59 60 61 … 773